31 October 2024
HeiQ Plc
("HeiQ" or "the Company")
Notice of Annual General Meeting
HeiQ Plc (LSE: HEIQ), a leading company in materials innovation and hygiene technologies, announces that it will hold its Annual General Meeting ("AGM") at 12:00pm on Monday 25 November 2024 at the offices of Russell Speechlys LLP, 5 Fleet Place, London, EC4M 7RD.
The Notice of AGM and related proxy forms will shortly be available to view on the Company's website, www.heiq.com/investors and have been dispatched to shareholders via the CREST system.
The Company's Annual Report and Accounts for the 18 month period ended 30 June 2024 will shortly be available to view on HeiQ's website, www.heiq.com/investors. A copy of the Annual Report will also be submitted to the Financial Conduct Authority in the United Kingdom via the National Storage Mechanism ("NSM"), available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. Copies will be posted to shareholders in the coming days.
For further information, please contact:
| HeiQ Plc Carlo Centonze (CEO) | +41 56 250 68 50 |
| Cavendish Securities plc (Broker) Stephen Keys / Callum Davidson | +44 (0) 207 397 8900 |
| SEC Newgate (Media Enquiries) Elisabeth Cowell / Molly Gretton / Tom Carnegie | +44 (0) 20 3757 6882 |
About HeiQ
Founded in 2005, HeiQ is a Swiss-based international company that is a global leader in biotech ingredients and specialty chemicals for diverse applications such as textiles, flooring, building materials, glass, plastics, probiotic cleaning, cosmetics, and more. Working with more than 1000 partners in over 60 countries, our goal is to infuse ordinary products with extraordinary qualities, offering our co-creation partners sustainable and disruptive solutions across industries.
Our business model focuses on the commercialization of existing and as well as the incubation of new technologies, driving shareholder value through sales growth, entry into lucrative markets, and disruptive innovation. This model consists of three distinct technology ventures, being HeiQ AeoniQ, HeiQ Xpectra, and HeiQ GrapheneX, and three growth-orientated business units being HeiQ Textiles & Flooring, HeiQ Life Sciences, and HeiQ Antimicrobials.
We have a robust track record of innovation, with over 200 technologies developed in partnership with 300 major brands, including Hanes, Burberry, HUGO BOSS, Lycra, Zara, Itochu, Bosch Siemens, Ecolab, Woellner, Americhem, Lixil, and many more. Our global team comprises about 200 professionals from 30 nationalities across five continents. We're committed to shaping a future where everyday products drive positive change, one innovation at a time.
To learn more about HeiQ and our innovative solutions, visit www.heiq.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.